-
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 million, with cell population frequencyCatalog #: CC-2703P
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell population frequency information
Sales unit: Ampule -
CompareTheraPEAK® AmpliCell® Recombinant Cytokines – IL-2, 10 µgCatalog #: AC-HU02-10GMPAmpliCell® recombinant cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.Sales unit: each
-
CompareX-VIVO® 15 Serum-free Hematopoietic Cell MediumCatalog #: BE02-060Q
X-VIVO® 15, Serum-free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree, 1 L
Sales unit: each -
CompareX-VIVO® 15 Serum-free Hematopoietic Cell MediumCatalog #: 02-060Q
X-VIVO® 15, Serum-free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree, 1 L
Sales unit: each -
CompareAmpliCell® Recombinant Cytokines – IL-2, 10 µgCatalog #: AC-HU02-10RUOAmpliCell® recombinant cytokines are designed to deliver reliable, consistent, and native-like performance across research, cell therapy, and biomanufacturing applications.
Sales unit: each -
CompareP3 Primary Cell 4D-Nucleofector® X Kit LCatalog #: V4XP-3024
For efficient transfection of specific primary cells, e.g. human T cells, CD34 or rat neurons, in the 4D-NucleofectorTM X Unit (100 µL format).
Do you need a quote right away? Add this product to your shopping cart, go to your cart and click on “Generate Quote”. Your quote will be available straight away to view, save online, and download in PDF format.
Sales unit: kit -
CompareP3 Primary Cell 4D-Nucleofector® LV Kit LCatalog #: V4LP-3002For larger scale transfection of primary cells, e.g. human T cells or CD34+ hematopoietic stem cells in the 1 mL NucleocuvetteTM Cartridge format when working with the 4D-NucleofectorTM LV UnitSales unit: kit
-
CompareHuman Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 millionCatalog #: CC-2703
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: Ampule -
CompareTheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell MediumCatalog #: BP04-744Q
TheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell Medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L
Sales unit: Bottle -
CompareTheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell Medium with recombinant transferrinCatalog #: BEBP02-054Q
TheraPEAK® X-VIVO® 15, Serum-free Hematopoietic Cell Medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L
Sales unit: each
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Large-scale editing of human T cells -
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell ExpansionThis poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.